Your browser doesn't support javascript.
loading
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines.
Digiacomo, Graziana; Fumarola, Claudia; La Monica, Silvia; Bonelli, Mara A; Cretella, Daniele; Alfieri, Roberta; Cavazzoni, Andrea; Galetti, Maricla; Bertolini, Patrizia; Missale, Gabriele; Petronini, Pier Giorgio.
Afiliação
  • Digiacomo G; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Fumarola C; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • La Monica S; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Bonelli MA; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Cretella D; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Alfieri R; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Cavazzoni A; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Galetti M; Istituto Nazionale per l'Assicurazione contro gli Infortuni sul Lavoro (INAIL) Research, Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Rome, Italy.
  • Bertolini P; Paediatric Hematology Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Missale G; Department of Medicine and Surgery, University of Parma, Parma, Italy.
  • Petronini PG; Unit of Infectious Diseases and Hepatology, University Hospital of Parma, Parma, Italy.
Front Oncol ; 10: 563249, 2020.
Article em En | MEDLINE | ID: mdl-33072590

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Itália